Lord Hunt of Kings Heath
Shadow Spokesperson (Health), Shadow Deputy Leader of the House of Lords
To ask Her Majesty’s Government whether they plan to ask NHS England to consult with patients on the decision to delist cancer drugs.
Earl Howe
The Parliamentary Under-Secretary of State for Health
NHS England consulted, during October 2014, on proposed changes to the Cancer Drugs Fund (CDF) process to allow a re-evaluation of drugs/indications on the national Cancer Drugs Fund List and the incorporation of an evaluation of a drug’s cost into the CDF prioritisation process.
We understand that NHS England does not plan to undertake any further consultation on the most recent decisions of the CDF panel which were announced on 12 January 2015.
Does this answer the above question?
Yes0 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.